Teva soars on ‘positive’ trial results for inflammatory bowel disease treatment
Shares in Israel’s Teva Pharmaceutical Industries surged after the generic drug giant said that a clinical study of its duvakitug drug for the treatment of ulcerative colitis and Crohn’s disease produced “positive results’’ and met its primary goals. In a …